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Abstract. Alanine aminotransferase (ALT) is a sensitive marker of 
dietary protein utilisation in fish. Three ALT isoforms (cALT1, 
cALT2 and mALT) encoded by two genes have been isolated from 
gilthead sea bream (Sparus aurata). Molecular characterization of 
ALT isozymes and gene promoters suggest involvement of cALT1 
and mALT in postprandial use of dietary amino acids, while cALT2 
seems associated to hepatic gluconeogenesis. Inhibition of hepatic 
cytosolic ALT activity stimulates pyruvate kinase and decreases the 
renewal rate of alanine in S. aurata. These findings point to ALT as a 
target to spare protein and improve catabolism of dietary 
carbohydrates in cultured fish. 
 
Introduction 
 
 Feeds supplied to fish in culture typically represent the largest variable 
cost in aquaculture producers’ budget. Nowadays an important concern in 
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aquaculture is to reduce the amount of dietary protein and to increase the 
content of cheaper nutrients to replace fishmeal [1]. In addition, since a 
large quantity of wild-caught fish is used as a source of fishmeal for 
aquafeeds, a reduction in the amount of protein supplied with the diet to 
fish in culture will alleviate pressure and dependence on marine fisheries, 
which are often overexploited [2–4]. Moreover, an excess of protein in the 
diet of farmed fish enhances amino acid degradation and eutrophication of 
local waters as a result of increased excretion of ammonia and organic 
compounds [5,6]. 
 Most fish species produced by aquaculture, such as gilthead sea bream 
(Sparus aurata), turbot and sea bass, are carnivorous ectothermic species 
and efforts to partially substitute dietary protein by other nutrients are 
limited by the metabolic features of these animals. Carnivorous fish 
present low capacity to metabolise dietary carbohydrates [7–9]. The 
metabolism of carnivorous fish is adapted to a preferential use of dietary 
amino acids as the main source for metabolic energy production.  
 Alanine aminotransferase (ALT; EC 2.6.1.2), also known as glutamate 
pyruvate transaminase, plays a major role in amino acid metabolism and 
gluconeogenesis by catalysing the reversible transamination between                 
L-alanine and -ketoglutarate to form pyruvate and L-glutamate. 
Therefore, ALT constitutes an important link between amino acids, 
carbohydrates and energy metabolism (Fig. 1). 
 ALT is a homodimer formed by two subunits of 50 kDa. Each subunit 
binds a molecule of the coenzyme pyridoxal-5-phosphate (PLP), which is 
necessary for enzyme activity. In mammals, the hepatic activity of ALT is 
regulated by hormonal and nutritional status, and its expression levels 
increase in rats fed with high protein diets, during starvation, after 
treatment with cortisol or -adrenergic agonists, and in diabetic animals 
[10,11]. ALT and aspartate aminotransferase (AST) are quantitatively the 
most important aminotransferases in the fish liver [12]. Nevertheless, ALT 
activity is more sensitive to changes in the nutritional status than AST in S. 
aurata and other fish species. 
 In the present review we will address current knowledge of the 
nutritional regulation of ALT expression in fish and its potential use as a 
biotechnological target to enhance carbohydrate catabolism for energy 
purposes, and preserve dietary amino acids for growth in order to spare 
protein and improve the sustainability of aquaculture. 
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Figure 1. Role of ALT in the hepatic metabolism. 
 
1. Hepatic ALT activity as a marker of dietary protein utilisation 
in fish 
 
 Partial substitution of dietary protein by carbohydrates promotes a 
metabolic adaptation that involves stimulation of key enzymes in 
glycolysis and pentose phosphate pathway in the liver of S. aurata [13–17]. 
Furthermore, supply of high protein/low carbohydrate diets increased ALT 
activity, while AST remained unaffected (Fig. 2A) [13,17]. Similar results 
were reported for Atlantic salmon [18] and rainbow trout [19,20]. This 
finding argues for a central role of ALT in the metabolic adaptation to 
changes in dietary nutrient composition. The increase in liver ALT activity 
in fish fed high protein diets may contribute to an efficient use of dietary 
amino acids either for growth or as a substrate for gluconeogenesis.  
 Hepatic ALT activity decreases in S. aurata following long-term 
starvation, whereas AST activity shows a slight tendency to increase                   
[13]. The effect of starvation on ALT and AST activities in other                  
fishes is variable and does not follow a clear pattern among different species.  
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Figure 2. Nutritional regulation of ALT activity in the liver of S. aurata. (A) Effect 
of protein/carbohydrate dietary content on ALT and AST activity. Different letters 
indicate significant differences for ALT activity (lower-case letters) among diets. No 
significant differences were found for AST [17]. (B) Effect of ration size on somatic 
growth rate (SGR, expressed as weight gain percentage per day) and the hepatic 
activity of ALT and AST in S. aurata. Different letters indicate significant 
differences for ALT activity (lower-case letters) and SGR (upper-case letters) among 
ration sizes. No significant differences were found for AST [13].  
 
Feeding Sparus aurata with different energy levels showed that liver ALT 
enzyme activity correlates with ration size and somatic growth rate. In 
contrast, regardless of the ration size no significant differences in AST 
activity were observed (Fig. 2B) [13]. 
 
2. Molecular cloning, subcellular localization, and kinetic 
properties of Sparus aurata ALT isozymes 
 
 Biochemical studies on rat and human ALT suggested the presence of 
soluble isoforms of ALT in cytosol and mitochondria [21–24]. The fact that 
Km for alanine of rat mitochondrial ALT is one order of magnitude lower 
than the value of cytoplasmic ALT, led to the assumption that pyruvate 
formation from alanine is a major function of mitochondrial ALT [25]. 
However, later reexamination of the subject indicated that a considerable 
part of alanine-derived pyruvate originates in cytoplasm and that 
contribution of rat mitochondrial ALT activity during gluconeogenesis is 
negligible compared with that of the cytoplasmic enzyme [26]. In addition, 
presence of several cytosolic ALT and mitochondrial ALT isozymes have 
been demonstrated in mammalian tissues [27–30]. The metabolic function of 
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each ALT isoform in the cell and the molecular mechanism that generates 
ALT isoforms in mammals remain unknown. 
 Similarly as in mammals, distribution of ALT activity in liver extracts 
from S. aurata showed that more than 85 % of total ALT activity localizes to 
the cytosol, whereas mitochondrial ALT corresponds to about 14% of total 
ALT activity [31]. Three ALT isozymes were isolated from S. aurata 
tissues, named cALT1, cALT2 and mALT [31,32]. Alternative splicing of 
cALT gene generates cALT1 and cALT2, while a separate gene encodes 
mALT. Compared to cALT1 messenger, cALT2 mRNA contains an extra 
exon with an upstream translational start site that results in the inclusion of 
23 amino acid residues at the N-terminus of the protein [32]. Considering 
that polyasparagine and polyglutamine regions are involved in protein-
protein interaction through the formation of a polar zipper of hydrogen 
bonds between the side chains [33], presence of an asparagine-rich region in 
cALT2 suggests regulation of the enzyme activity by aggregation or 
interaction with effector proteins. In this regard, aggregation of ALT 
molecules gives rise to active oligomers during the purification of the rat 
liver enzyme [34]. 
 The primary structure of S. aurata mALT protein shares an identity of 
77 and 74 % with cALT1 and cALT2, respectively. Alignment of peptide 
sequences of piscine cALTs and mALT with mammalian ALT1 and ALT2 
shows an identity of 66-71 %. The overall similarity with mammalian ALTs 
suggests a high degree of conservation of structure and reaction mechanism 
in vertebrate evolution. In the rat liver cytosolic ALT, Lys
313
 resides in the 
active site and participates in binding to the coenzyme PLP [35,36]. This 
residue is conserved in S. aurata ALTs and corresponds to Lys
309
, Lys
332
 and 
Lys
372
, in cALT1, cALT2 and mALT, respectively. 
 Subcellular localization of S. aurata ALT isoforms was examined by 
means of confocal fluorescence microscopy and immunodetection after 
expression of enhanced green fluorescent protein (GFP)-fusion proteins in 
transiently transfected eukaryotic cells. Both cALT1 and cALT2 show a 
diffuse distribution in the cell, indicating that both isoforms mostly exhibit 
cytosolic localization. A minor part of the two proteins is also present in 
vesicle-like structures [31,32]. 
 Consistent with the physicochemical properties of a mitochondrial 
targeting signal presequence [37–40], the N-terminus of mALT comprises 
twelve positively charged, seventeen hydroxylated, and many hydrophobic 
residues within the first 70 amino acids. Indeed, fusion of GFP to the                     
C-terminus of mALT (mALT-GFP) leads to colocalization of the fusion 
protein with mitochondrial markers. On the contrary, fusion of GFP to 
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mALT N-terminus or to the C-terminus of a mALT mutant lacking the                       
N-terminal end blocks entry of the protein into mitochondria, and confirms 
presence of a mitochondrial targeting signal at the N-terminus of mALT. 
Immunodetection of CHO cells transfected with mALT-GFP revealed that 
although the protein is mostly found in the mitochondrial fraction, it is also 
detected in cytosol, although to a lesser extend and with higher molecular 
weight [31]. This finding argues for mALT import and processing into 
mitochondria according to the presequence import pathway, where basic N-
terminal presequences are directed into mitochondria through interaction 
with translocases of the outer and inner membranes [41–43]. 
 Expression of cALT1 in S. aurata is mainly found in liver, brain, 
skeletal muscle, intestine and kidney. No expression of cALT1 is detected in 
heart, gill or spleen. In contrast, maximal expression of cALT2 occurs in 
these three organs. Moderate cALT2 expression is observed in intestine, 
kidney and liver, whereas low cALT2 mRNA levels are detected in brain 
and skeletal muscle. mALT is ubiquitously expressed, with the higher levels 
in kidney, followed by liver, and intestine [32,44].  
 The occurrence of various ALT isozymes in tissues such as the liver 
supports the notion that ALT isoforms may play different roles in the cell. 
To unravel the molecular functions of S. aurata ALT proteins, kinetic 
characterisation of ALT isozymes was performed after expression of fish 
enzymes in Saccharomyces cerevisiae (Table 1) [32,44]. Kinetic properties 
of ALT isoforms were determined considering catalysis of the reaction in the 
direction of L-glutamate formation (forward reaction) and the direction of  
L-alanine formation (reverse reaction). Analysis of the forward/reverse ALT 
activity ratio and the fact that the reverse reaction mechanism of cALT2 
followed a ping-pong bireactant system with, in contrast to cALT1, strong 
double substrate inhibition suggest that cALT2 preferentially converts                 
L-alanine to pyruvate. Mutagenesis analysis demonstrated that residues 3-13 
of cALT2 are essential for the reaction direction preference exhibited by this 
enzyme [32].  
 Taking into consideration that cALT1 and cALT2 expression in                          
S. aurata is found in tissues that can undergo both glycolysis and 
gluconeogenesis, such as liver, kidney and intestine, it is conceivable that 
in these particular tissues cALT2 expression can be more restricted to 
metabolic conditions that favour gluconeogenesis. In contrast, cALT1 
prevails during the fed state, which is characterised by elevated glycolysis 
and deviation of excess pyruvate to form L-alanine and provide                      
2-oxoglutarate to replenish the citric acid cycle in a metabolic situation 
where intermediates of this pathway can be used for biosynthetic purposes.  
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Table 1. Kinetic parameters of S. aurata cALT1, cALT2 and mALT [32,44]. 
 
     
  cALT1 cALT2 mALT 
  Forward reaction    
 Km
Ala (mM) 1.8 2.2 2.2 
 Km
2-Oxo (mM) 0.05 0.05 0.21 
 Vmax (mmol/min/g) 57 14697 403 
 Vmax / Km
Ala
 0.03 6.65 0.18 
 Vmax / Km
2-Oxo
 1.18 288 1.89 
     
  Reverse reaction    
 Km
Glu (mM) 15.9 4.5 11.3 
 Km
Pyr (mM) 0.69 0.15 0.32 
 Vmax (mmol/min/g) 11.6 20.9 534 
 Vmax / Km
Glu
 0.001 0.005 0.047 
 Vmax / Km
Pyr
 0.02 0.14 1.68 
 Ki
Glu (mM)  34.9  
 Ki
Pyr (mM)  36.5  
 
cALT2 was the only cALT isoform detected in non-gluconeogenic tissues 
such as heart, gill and spleen. This may be associated with the higher 
regulatory and kinetic versatility exhibited by this enzyme [32]. The 
metabolic function of cALT2 in these tissues seems to differ from the role 
exerted in liver, kidney or intestine, and might be related with processes such 
as amino acid interconversion and deamination. 
 Kinetic characterisation of S. aurata mALT indicates that this enzyme 
preferentially catalyzes the reaction in the pyruvate-forming direction [44].  
 
3. Nutritional and hormonal regulation of cALT1, cALT2 and 
mALT expression 
 
 To analyse the functional role of ALT isozymes in intermediary 
metabolism, the effect of nutritional status and hormonal regulation was 
addressed on the expression of cALT1, cALT2 and mALT in S. aurata. 
Long-term starvation increases cALT2 mRNA levels and reduces cALT1 
expression in liver of S. aurata [32]. Up-regulation of cALT2 expression 
in starved fish is consistent with preference of cALT2 in catalysing the 
production of pyruvate from L-alanine in a metabolic condition with 
decreased levels of hepatic pyruvate [45]. Indeed, alanine is the main 
amino acid released by skeletal muscle and taken up by the liver in 
starvation [46].  
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 Food intake participates in short-term modulation of hepatic cALT1 
and cALT2 expression. Consistent with the expression pattern in starved 
fish, cALT2 mRNA abundance decreased to minimum levels after a 
postprandial period of 4-8 hours. In contrast, the hepatic expression of 
cALT1 reached maximal values 2-8 hours following food intake. Likewise, 
administration of glucose and insulin to S. aurata significantly decreased 
cALT2 mRNA 6 hours after treatment, while cALT1 mRNA levels 
remained unaffected. Considering together kinetic data and nutritional 
regulation of cALTs expression, these observations point to up-regulation 
of cALT2 in conditions associated with increased gluconeogenesis, 
whereas cALT1 seems more involved in postprandial utilisation of dietary 
nutrients [32]. 
 Similarly as for cALT1, starvation decreased mALT mRNA levels in 
liver and kidney of S. aurata [44,47]. Analysis of mALT expression in 
liver of fed S. aurata indicated a tendency to increase at postprandial time 
6 hours [47]. Possibly, in the fed state cooperation of cALT1 and mALT 
allows addressing of dietary amino acids into the mitochondria to provide 
substrates for energy purposes. The fact that feeding S. aurata with high 
protein diets increases hepatic cALT1 expression while does not affect 
mALT [47,48], suggests that mALT is more involved in energy production 
from amino acids to maintain basal metabolism, whereas cALT1 would 
metabolise excess of dietary amino acids in the cytosol. 
 In mammals, type 2 diabetes leads to increased gluconeogenesis in the 
liver [49–51], and among the amino acids, alanine is the most effective 
gluconeogenic precursor [52]. Consistent with up-regulation of cALT2 
expression in gluconeogenic conditions in liver, the diabetogenic action of 
streptozotocin (STZ), a glucosamine-nitrosourea derivative that causes  cell 
necrosis and that is widely used to generate diabetic animal models [53–55], 
leads to a marked increase in the hepatic expression of cALT2 in S. aurata, 
whereas cALT1 and mALT mRNA levels show a tendency to decrease 
[32,47]. The requirement for gluconeogenic substrates may be critical to 
enhance hepatic cALT2 expression in STZ-induced diabetic S. aurata. 
 
4. Transcriptional control of Sparus aurata cALT and mALT 
gene promoters 
 
 To gain insight into the transcriptional regulation of ALT genes in fish, 
the promoter regions of cALT and mALT from S. aurata were isolated and 
characterised. The cALT and mALT promoters were the first ALT gene 
promoters reported for animals others than humans [44,56]. 
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 The S. aurata cALT promoter contains an initiator (Inr)-like element 
that overlaps the transcription start site. Sequential 5’ deletions of promoter 
reporter constructs and analysis of transcriptional activity in sea bass larvae-
derived SBL cells, allowed to conclude that the promoter region within 89 
bp upstream from the transcriptional start constitutes the core functional 
promoter of this gene. Transient transfection experiments and EMSA 
analysis demonstrated that p300, a transcriptional coactivator that modulate 
the activity of a wide array of transcription factors [57,58], confers an 
activating signal on the cALT promoter by forming part of a complex that 
binds to a response element located at position -73 to -60 bp upstream from 
the transcription start site [56]. Recruitment of proteins with histone 
acetyltransferase activity, such as p300, to the Inr element of cALT promoter 
may provide an open DNA configuration that makes the site of 
transcriptional initiation more accessible to other transcription factors and 
the basal transcriptional machinery. In this regard, targeting of p300 to the 
Inr element might enable the recruitment of TFIID to the cALT promoter, as 
suggested for other TATA-less Inr-containing promoters [59,60]. 
 Apart from acetylating histones, p300 acetylates several transcription 
factors in a regulated manner [61]. Transfection experiments in SBL cells 
showed that an acetyltransferase-deficient mutant of p300 failed to induce            
S. aurata cALT promoter activity, indicating that acetyltransferase activity 
of p300 is essential for p300-mediated transcriptional activation of cALT 
[56]. Thus, p300 may induce cALT promoter activity by acetylating histones 
and transcription factors. Indeed, EMSA assays and site-directed 
mutagenesis revealed that c-Myb transactivates S. aurata cALT promoter by 
binding to a c-Myb box at position -52 to -35 bp upstream from the 
transcriptional start. c-Myb-dependent transactivation of cALT occurred 
irrespective of the p300 response element [56]. However, since p300-
mediated acetylation increases DNA binding activity of c-Myb and 
replacement of acetylated residues (lysines) in c-Myb by arginine 
dramatically decreases the transactivating capacity of c-Myb [62,63], p300-
mediated acetylation of c-Myb possibly enhances binding of c-Myb to the             
S. aurata cALT promoter (Fig. 3). 
 Given that conditions associated with increased gluconeogenesis, such 
as starvation and treatment with STZ, result in a marked increase of cALT2 
mRNA levels in the liver of S. aurata, cALT2 up-regulation can be 
responsible for serum increase of ALT activity under conditions associated 
with insulin resistance and development of type-2 diabetes [32]. In 
agreement with cALT2 expression, mRNA abundance of p300 and c-Myb 
increased in starved S. aurata and decreased in fish liver after the 
administration of insulin [56]. 
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Figure 3. Coactivator p300 and c-Myb transactivate the S. aurata cALT promoter. 
Schematic representation of the cALT promoter region, with the DNA wrapped 
around nucleosomes forming histones (depicted in a grey circle). By acetylating the 
histone tails and transcription factors, i.e. c-Myb, p300 can make the DNA more 
accessible to other regulatory proteins. In addition, p300 can form a physical bridge 
between transcription factors and the general transcription factors and RNA 
polymerase II (Pol II). Inr, initiator element. GTF, General Transcription Factors. 
Acetylation is represented by the symbol`l    . Figure adapted from [64]. 
 
 Functionality of the promoter region of S. aurata mALT was assayed in 
human kidney-derived HEK293 cells transfected with fusion constructs 
containing sequencial 5'-deletions of the isolated fragment. The promoter 
region within 49 bp upstream from the transcription start site constitutes the 
core functional promoter for mALT gene. HNF4α transactivates the S. 
aurata mALT gene promoter by binding to a response element located at 
position -63 to -39 bp upstream from the transcriptional start [44]. Tissue 
distribution of S. aurata HNF4α expression, mainly in kidney, liver and 
intestine, correlates well with that observed for mALT [44]. 
 There is increasing evidence suggesting a major role for HNF4  in the 
kidney [65–67], and involvement of this transcription factor in 
transactivation of genes involved in amino acid metabolism such as tyrosine 
aminotransferase and ornithine aminotransferase [68,69]. In the fish kidney, 
dietary amino acids are used as substrates for oxidation and gluconeogenesis 
[70]. Under gluconeogenic conditions, such as starvation and STZ-treatment, 
down-regulation of HNF4  expression correlates with decreased mALT 
mRNA levels in kidney of S. aurata, which suggest a central role of HNF4α 
in the transcriptional regulation of mALT. Expression of mALT in this tissue 
might be mainly involved in the oxidation of amino acids for energetic 
purposes rather than for providing gluconeogenic substrates [44]. 
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5. Effect of ALT inhibition on the intermediary metabolism of 
Sparus aurata 
 
 Bearing in mind the central role of ALT linking amino acids, 
carbohydrates and energy metabolism, ALT was considered a candidate 
gene target to spare protein and improve the metabolic utilisation of 
dietary carbohydrates. To test this hypothesis, the metabolic effect of 
inhibiting cytosolic ALT activity on intermediary metabolism was 
addressed in S. aurata using amino-oxyacetate (AOA), an inhibitor of 
PLP-dependent transaminases [71]. Although in vitro AOA inhibits ALT 
activity in cytosolic and mitochondrial fractions isolated from liver of                  
S. aurata, AOA only affects cytosolic ALT activity in vivo, which suggests 
that AOA does not enter mitochondria and thus cannot inhibit mALT [72]. 
Consequently, the effect of AOA in vivo may be restricted to cytosolic 
ALT activity and, during the fed state, essentially to cALT1, the cALT 
isoform mainly involved in postprandial utilisation of dietary nutrients 
[32]. Considering that mALT activity accounts for as less as about 14 % of 
total ALT activity in the liver of fed S. aurata [31], the use of AOA in vivo 
appeared to be suitable to specifically inhibit ALT activity of cytosolic 
fractions.  
 Dietary AOA supplementation to S. aurata for 30 days causes a 
significant inhibition on ALT activity, without affecting ALT protein 
levels and irrespective of nutrient composition of the diet. The most 
remarkable effects of AOA-dependent ALT inhibition on the intermediary 
metabolism is a significant increase in pyruvate kinase (PK) activity, a key 
enzyme in glycolysis, without affecting the gluconeogenic fructose-1,6-
bisphosphatase activity nor glycemia [44]. 
 It was reported that glutamate behaves as an inhibitor of PK activity, 
while alanine is a strong allosteric inhibitor of hepatic PK [73]. Taking into 
account that dietary AOA supplementation decreased glutamate and 
alanine levels in the liver of S. aurata, increased PK activity in the liver 
after long-term exposure to AOA may result from: i) low glutamate levels 
and the consequent loss of the glutamate-dependent PK inhibition; and ii) 
reduction of alanine concentration as a consequence of ALT inhibition.                 
1
H NMR studies showed that inclusion of AOA to the diet also decreased 
hepatic glycogen. Moreover, 
2
H NMR analysis indicated decreased                
2
H-enrichment level of alanine methyl hydrogens in the liver                       
of fish exposed to AOA irrespective of the composition of the diet [72].  
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Figure 4. Effect of dietary amino-oxyacetate supplementation on the intermediary 
metabolism of S. aurata. 
 
Altogether, these results suggest that AOA-dependent inhibition of 
cytosolic ALT activity in the liver stimulates glycolysis and decreases the 
renewal rate of alanine, which in turn may improve metabolism of dietary 
carbohydrates and spare protein (Fig. 4). 
 
6. Conclusion 
 
 Molecular characterisation of S. aurata ALT isozymes including 
cloning and subcellular localisation of ALT isoforms, nutritional and 
hormonal regulation of ALT expression, enzyme kinetics, and 
transcriptional regulation of cALT and mALT gene promoters led to 
hypothesize that inhibition of cytosolic ALT activity could be useful to 
improve the use of dietary carbohydrates and spare protein in 
aquaculture. Preliminary studies showed that AOA-dependent inhibition 
of cALT activity gave rise to promising results including stimulation of 
PK activity and decreased renewal rate of alanine in the liver. To 
perform a more robust protein-sparing effect in order to promote an 
important increase in the use of dietary carbohydrates for energy 
production and preserve dietary amino acids for growth in cultured fish, 
strategies to apply in future studies should consider: i) use of interference 
RNA (iRNA) to specifically down-regulate the expression of cALT 
messengers; ii) explore the impact of post-translational mechanisms that 
may control ALT activity, such as protein-protein interactions; and iii) 
increase genomic and transcriptomic information available for S. aurata 
and other fish species with commercial interest to identify other 
candidate genes to perform a multifactorial action to improve the 
utilisation of dietary nutrients in fish farming. 
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